Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Corman

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Diseases of the Colon and Rectum|February 1, 1994
Immunoscintigraphy with 111In-satumomab pendetide in patients with colorectal adenocarcinoma: performance and impact on clinical managementM L Corman, S Galandiuk, G E Block, et al.
Journal of Medicinal Chemistry|September 15, 1995
erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationshipsR C Schnur, M L Corman, R J Gallaschun, et al.
Journal of Medicinal Chemistry|September 15, 1995
Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivativesR C Schnur, M L Corman, R J Gallaschun, et al.
Journal of Medicinal Chemistry|May 23, 1997
Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonistY L Chen, R S Mansbach, S M Winter, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|January 18, 2006
Consensus conference on the stapled transanal rectal resection (STARR) for disordered defaecationM L Corman, A Carriero, T Hager, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2008
Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophreniaC J Schmidt, D S Chapin, J Cianfrogna, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Diseases of the Colon and Rectum|February 1, 1994
Immunoscintigraphy with 111In-satumomab pendetide in patients with colorectal adenocarcinoma: performance and impact on clinical managementM L Corman, S Galandiuk, G E Block, et al.
Journal of Medicinal Chemistry|September 15, 1995
erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationshipsR C Schnur, M L Corman, R J Gallaschun, et al.
Journal of Medicinal Chemistry|September 15, 1995
Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivativesR C Schnur, M L Corman, R J Gallaschun, et al.
Journal of Medicinal Chemistry|May 23, 1997
Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonistY L Chen, R S Mansbach, S M Winter, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|January 18, 2006
Consensus conference on the stapled transanal rectal resection (STARR) for disordered defaecationM L Corman, A Carriero, T Hager, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2008
Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophreniaC J Schmidt, D S Chapin, J Cianfrogna, et al.
Pageof 9